1) 日本脳卒中学会脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015 (追補 2017), 協和企画, 東京, 2017.
2) North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991 ; 325 : 445-53.
3) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995 ; 273 : 1421-8.
4) Abbott AL. Medical (nonsurgical) intervenetion alone is now the best for prevention of stroke associated with asymptomatic severe carotid stenosis : results of a systemic review and analysis. Stroke 2009 ; 40 : e573-83.
5) Abbott AL. Stroke rates associated with asymptomatic carotid stenosis and medical treatment alone continue to fall : Results of an updated meta-analysis. (abst.) International Stroke Conference 2013, Honolulu, Feb 6-8, 2013.
6) Mackey AE, Abrahamowicz M, et al. Outcome of asymptomatic patients with carotid disease. Asymptomatic Cervical Bruit Study Group. Neurology 1997 ; 48 : 896-903.
7) Marquardt L, Geraghty OC, et al. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment : a prospective, population-based study. Stroke 2010 ; 41 : e11-e17.
8) den Hartog AG, Achterberg S, et al. Asymptomatic carotid artery stenosis and the risk of ischemic stroke according to subtype in patients with ckinical manifest arterial disease. Stroke 2013 ; 44 : 1002-7.
9) Chimowitz MI, Lynn MJ, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011 ; 365 : 993-1003.
10) Amarenco P, Labreuche J, et al. Statins in stroke prevention and carotid atherosclerosis : systematic review and up-to-date meta-analysis. Stroke 2004 ; 35 : 2902-9.
11) Amarenco P, Labreuche J. Lipid management in the prevention of stroke : review and updated metaanalysis of statins for stroke prevention. Lancet Neurol 2009 ; 8 : 453-63.
12) Amarenco P, Goldstein LB, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack : the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007 ; 38 : 3198-204.
13) Hosomi N, Nagai Y, et al. The Japan Statin Treatment Against Recurrent Stroke (J-STARS) : A multicenter, randomized, open-label, parallel-group study. EBioMedicine 2015 ; 2 : 1071-8.
14) 日本動脈硬化学会. 動脈硬化性疾患予防ガイドライン 2017年版, 東京, 一般社団法人日本動脈硬化学会, 2017.
15) Sabatine MS, Giugliano RP, et al. Evolocumab and clinical outcome in patients with cardiovascular disease. N Engl J Med 2017 ; 376 : 1713-22.
16) Uchiyama S, Nakamura T, et al. New modalities and aspects of antiplatelet therapy for stroke prevention. Cerebrovasc Dis 2006 ; 21 Suppl 1 : 7-16.
17) Markus HS, Droste DW, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptom carotid stenosis evaluated using Doppler embolic signal detection : the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005 ; 111 : 2233-40.
18) Wong KS, Chen C, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolization in patients with acute symptom cerebral or carotid artery stenosis (CLAIR study) : a randomized, open-label, blinded-endpoint trial. Lancet Neurol 2010 ; 9 : 489-97.
19) Kwon SU, Cho YJ, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis : the multi-center double-blind placebo-controlled trial of cilostazol in symptom intracranial stenosis. Stroke 2005 ; 36 : 782-6.
20) Uchiyama S, Sakai N, et al. Final results of cilostazol-aspirin therapy against recurrent stroke with intracranial artery stenosis (CATHARSIS). Cerebrovasc Dis Extra 2015 ; 5 : 1-13.
21) Wang Y, Wang Y, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013 ; 369 : 11-9.
22) Johnston C, Easton JD, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk transient ischemic attack. N Engl J Med 2018 ; 379 : 215-25.
23) Wong KS, Wang Y, et al. Early dual versus mono antiplatelet therapy for acute non-caardioembolic ischemic stroke or transient ischemic attack : an updated systematic review and meta-analysis. Circulation 2013 ; 128 : 1656-66.
24) Rothwell PM, Howard SC, et al. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003 ; 34 : 2583-92.
25) Yamauchi H, Fukuyama H, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1992 ; 40 : 1992-8.
26) Munster AB, Franchini AJ, et al. Temporal trends in safety of carotid endarterectomy in asymptomtic patients : systematic review. Neurology 2017 ; 85 : 365-72.